Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANOPEC 3: CD34+ Cells in Aortic Aneurysm
NCT02919709Unknown
- Sponsor
- CHU de Besançon
- Start
- Nov 2013
- Primary completion
- Nov 2018
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by CHU de Besançon. Primary endpoint: Progenitor cells CD34+ blood levels at 24 months. Status: unknown.
Beyond the preview
Go deeper on NCT02919709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02919709.